5-HT and antidepressants: new views from microdialysis studies
- 1 July 1993
- journal article
- other
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 14 (7) , 262
- https://doi.org/10.1016/0165-6147(93)90125-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake ratNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1993
- Serotonin 5‐HT1A Autoreceptor Blockade Potentiates the Ability of the 5‐HT Reuptake Inhibitor Citalopram to Increase Nerve Terminal Output of 5‐HT In Vivo: A Microdialysis StudyJournal of Neurochemistry, 1993
- Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis studyEuropean Journal of Pharmacology, 1992
- Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortexBrain Research, 1992
- Serotonin Function and the Mechanism of Antidepressant ActionArchives of General Psychiatry, 1990
- 5‐HT1 agonists reduce 5‐hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysisBritish Journal of Pharmacology, 1989
- Autoradiography of antidepressant binding sites in the human brain: localization using [3h]imipramine and [3h]paroxetineNeuroscience, 1988
- Serotonergic Neuronal SystemsJournal of Clinical Psychopharmacology, 1987
- Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonistsSynapse, 1987